Antibody-targeted chemotherapy with CMC-544: a CD22-targeted immunoconjugate of calicheamicin for the treatment of B-lymphoid malignancies.
DiJoseph JF, Armellino DC, Boghaert ER, Khandke K, Dougher MM, Sridharan L, Kunz A, Hamann PR, Gorovits B, Udata C, Moran JK, Popplewell AG, Stephens S, Frost P, Damle NK.
DiJoseph JF, et al. Among authors: hamann pr.
Blood. 2004 Mar 1;103(5):1807-14. doi: 10.1182/blood-2003-07-2466. Epub 2003 Nov 13.
Blood. 2004.
PMID: 14615373
Free article.